Bispecific Antibodies in the Management of Multiple Myeloma

Episode 253 · May 24th, 2024 · 42 mins 8 secs

About this Episode

Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.

CME information and select publications here.